Tryngolza

head to head against clash football helmets fight combat
Pharma

Arrowhead data set up Redemplo for hypertriglyceridemia nod

Arrowhead has reported data from two phase 3 trials that could set the company up for Redemplo to gain approval to treat severe hypertriglyceridemia.
Kevin Dunleavy Jul 22, 2026 10:52am
Ionis headquarters

FDA approves transformational expansion of Ionis’ Tryngolza

Jun 25, 2026 8:13am
Podcast
Abstract illustration of a light blue RNA strand twisting against a purple background with The Top Line podcast title

 A pivotal time for an RNA pioneer 

May 1, 2026 8:30am
price

Ionis slashes Tryngolza's price ahead of planned label expansion

Mar 25, 2026 2:59pm
Ionis headquarters

Ionis doubles its sales projection for Tryngolza in sHTG to $2B

Jan 13, 2026 3:45pm
arrow bullseye target on target

Arrowhead strikes true with first FDA approval

Nov 18, 2025 3:44pm